Skip to main content
SpringerLink
Log in
Book cover

Ulcus-Therapie pp 137–154Cite as

Andere Sekretionshemmer und Medikamente zur Förderung der Schleimhautresistenz

  • Conference paper

Part of the book series: Interdisziplinäre Gastroenterologie ((GASTROENTEROLOG))

Zusammenfassung

Die Gruppe dieser Substanzen zeichnet sich vorwiegend durch eine Hemmung der Säure- und/oder Pepsinsekretion aus. Die häufig gleichzeitig zu beobachtende Hemmung der Sekretion von Intrinsicfactor gilt als eine unerwünschte Nebenwirkung.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Archambault, A., Farley, A., Gosselin, D., Martin, F.: Multicentre double-blind study of duogastrone in the treatment of duodenal ulcers. Fourth Symposium on Carbenoxolone. Jones, F. A., Parke, D. V. (eds.), pp. 251–254. London: Butterworths 1975

    Google Scholar 

  2. Asano,T.: Study of gastric blood flow. VI. Congress Ther. Res. New Drugs. Osaka 1969, Rep. Vol., pp. 108–122

    Google Scholar 

  3. Bianchi Porro, G., Ferrara, A., Petrillo, M., Abbondati, G.: Attività inibitrice della tritiozina (ISF2001) e della propantelina sulla secrezione gastrica nell’uomo. Studio cross-over in doppio cieco. Minerva Gastroent. 22, 149–152 (1976)

    Google Scholar 

  4. Cocking, J.B., McCaig, J.B.: Effect of low dosage of carbenoxolone sodium on gastric ulcer healing and acid secretion. Gut 10, 219–225 (1969)

    Article  PubMed  CAS  Google Scholar 

  5. Collyns, A.H., Fordtran, J.S.: Controlled analysis of antacids and anticholinergics in modifying gastric acidity and peptic activity after steak in patients with duodenal ulcer. Gastroenterology 48, 812 (1965)

    Google Scholar 

  6. Corinaldesi, R., Luchetta, R., Miglioli, M., Ricci, P., Casadio, R., Barbara, L.: Effetti su secrezione e motilità gastrica nell’uomo della 4-(3,4,5-trimetossitio-benzoil) tetraidro- 1,4-ossazina (tritiozina). Atti XX Congr. Naz. Soc. Gastroent. Rendicont. di Gastroenterologia 7, 22–25(1975)

    Google Scholar 

  7. Cornet, A., Grivaux, M.: Recherches physiopathologiques sur le sulpiride en gastroenterologie. Bull. Mém. Soc. Méd. Hòp. 119, 753–760 (1968)

    CAS  Google Scholar 

  8. Doll, R., Hill, I.D., Hutton, C.F.: Treatment of gastric ulcer with carbenoxolone sodium and oestrogen. Gut 6, 10–24 (1965)

    Article  Google Scholar 

  9. Doll, R., Hill, I.D., Hutton, C., Underwood, D.J.: Clinical trial of a triterpenoid liquorice compound in gastric and duodenal ulcer. Lancet 1962 II, 793–796

    Article  Google Scholar 

  10. Domschke, W., Domschke, S., Classen, M., Demling, L.: Bedeutung der N-Acetylneuraminsäure im Magensaft - ein therapeutischer Aspekt. In: Das peptische Ulcus. Demling, L. (Hrsg.), S. 105–111. Stuttgart: Schattauer 1973

    Google Scholar 

  11. Dotevall, G.: Comment. Selected summaries. Gastroenterology 60, 1142–1143 (1971)

    Google Scholar 

  12. Dotevall, G., Schröder, G., Walan, A.: The effect of poldine, glycopyriolate, and 1-hyoscyamine on gastric secretion of acid in man. Acta med. scand. 177, 169–174 (1965)

    Article  PubMed  CAS  Google Scholar 

  13. Einig, D.: Ein neuer Sekretionshemmer: Ergebnisse einer Wirkungs- und Verträglichkeitsprüfung mit Gastrozepin. Therapiewoche 27, 1630–1638 (1977)

    CAS  Google Scholar 

  14. Feldmann, H., Gilat, T.: A trial of deglycyrrhizinated liquorice in the treatment of duodenal ulcer. Gut 12, 449–451 (1971)

    Article  Google Scholar 

  15. Feldman, M., Richardson, C.T., Peterson, W.L., Walsh, J.H., Fordtran, D.S.: Effect of low-dose propantheline on food-stimulated acid secretion. N. Eng. J. Med. 297, 1427- 1430(1977)

    Article  CAS  Google Scholar 

  16. Fritsch, W.-P., Schacht, U., Schölten, Th., Jäger, N., Hengels, K.-J., Müller, J., Strasser, K.: Cimetidinwirkung auf die durch intraoperativen elektrischen Vagusreiz freigesetzte H-Sekretion bei Patienten mit Ulcus duodeni. Verh. Dtsch. Ges. inn. Med.84, 1978 (in Druck)

    Google Scholar 

  17. Gibinski, K., Rybicka, J., Mikos, E., Nowak, A.: Double-blind clinical trial on gastro- duodenal ulcer healing with prostaglandin E2 analogues. Gut 18. 636–639 (1977)

    Article  PubMed  CAS  Google Scholar 

  18. Hammer, R., Bozler, G., Zimmer, A., Koss, F.W.: Pharmakokinetik und Metabolismus von LS 519-CI2 (Pirenzepin) beim Menschen. Therapiewoche 27, 1575–1593 (1977)

    CAS  Google Scholar 

  19. Hammer, R., Kaubisch, N., Kopitar, Z., Prox, A., Zimmer, A., Koss, F.W.: Untersuchungen zu Pharmakokinetik und Metabolismus von LS 519-C12 (Pirenzepin) an Ratte, Kaninchen und Hund. Therapiewoche 27, 1567–1574 (1977)

    CAS  Google Scholar 

  20. Hausamen, T.-U., Fritsch, W.-P.: Physiologie und Pathophysiologie gastrointestinaler Hormone der Gastrin- und Sekretingruppe. Teil II: Cholezytokinin-Pankreozymin und Sekretingruppe. Z. Gastroent. 15, 320–336 (1977)

    CAS  Google Scholar 

  21. Hausamen, T.-U., Fritsch, W.-P., Schölten, Th., Jungblut, R. M., Strohmeyer, G.: Behandlung peptischer Ulcera beim Zollinger-Ellison-Syndrom mit Histamin-h2-Rezeptor-Antagonisten. Dtsch. med. Wschr. 102, 1709–1712 (1977)

    Article  PubMed  CAS  Google Scholar 

  22. Horwich, L., Galloway, R.: Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation. Brit. med. J. 1976 11, 1274–1277

    Google Scholar 

  23. Hoskins, E.O.L.: Metoclopramide in benigne gastric ulceration. Postgrad, med. J. 49 (Suppl.4), 95–97 (1973)

    Google Scholar 

  24. Hunt, T., Abrains, M., Atkinson, M.: Carbenoxolone in the treatment of duodenal ulcer. A multicentre trial. Brit. J. din. Pract. 27,50–55 (1973)

    Google Scholar 

  25. Innes, I.R., Nickerson, M.: Drugs inhibiting the action of acetylcholine on structures innervated by postganglionic parasympathetic nerves. Antimuscarinic or atropinic drugs. In: The pharmacological basis of therapeutics, 3rd. Ed. Goodman, L.S., Gilman, A. (eds.), pp. 521–545. New York: Macmülan 1965

    Google Scholar 

  26. Kaye, M.D.: Anticholinergic drugs in duodenal ulcer. Gastroenterology 62, 502–504 (1972)

    PubMed  CAS  Google Scholar 

  27. Koelz, H. R., Fischer, J., Sachs, G., Blum, A. L.: A specific action of aspirin on gastric cell membrane. Gastroenterology 72, 1059/1082 (1977)

    Google Scholar 

  28. Konturek, S. J., Kwiencien, N., Swierczek, J., Oleksy, J., Sito, E., Robert, A.: Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Gastroenterology 70, 683–687 (1976)

    PubMed  CAS  Google Scholar 

  29. Leading article: Anticholinergics and duodenal ulcer. Lancet 1973 II, 1173

    Google Scholar 

  30. Mahl, G.F.: Anxiety, HCl-Secretion, and peptic ulcer etiology. Psychosom. Med. 12, 158–169(1950)

    PubMed  CAS  Google Scholar 

  31. Margolin, S. G.: The behavior of the stomach during psychoanalysis. A contribution to a method of verifying psychoanalytic data. Psychoanalytic Quart. 20, 349–357 (1951)

    CAS  Google Scholar 

  32. Masuda, M.: Results of a national scale statistical study of a double blind study. VI. Congress Ther. Res. New Drugs, Osaka 1969, Rep. Vol. 1–20

    Google Scholar 

  33. Middleton, W.R.J., Cooke, A. R., Stephen, D., Skyring, A. P.: Biogastrone in inpatient treatment of gastric ulcer. Lancet19651, 1030–1032

    Google Scholar 

  34. Misiewicz, J.J., Russell, R. I., Baron, J.H.: Treatment of duodenal ulcer with glycyrrhizinic-acid-reduced liquorice. A multicentre trial. Brit. med. J. 3, 501–503 (1971)

    Google Scholar 

  35. Mitchell, R.D., Hunt, J. W., Grossman, M.L: Inhibition of basal and postprandial gastric secretion by poldine and atropine in patients with peptic ulcer. Gastroenterology 43,400–406(1962)

    Google Scholar 

  36. Molle, M.: Sulpirid bei der’Behandlung von Gastroduodenalgeschwüren. Fortschr. Med. 93, 1077–1082(1975)

    PubMed  CAS  Google Scholar 

  37. Nagy, G.S.: Evaluation of carbenoxolon sodium in the treatment of duodenal ulcer. Gastroenterology 74, 7–10 (1978)

    PubMed  CAS  Google Scholar 

  38. Newman, A., Pradc, J., DeMoreas-Filho, P., et al.: The effect of intravenous infusion of prostaglandins E2 and F2 on human gastric function. Gut 16, 272–276 (1975)

    Article  PubMed  CAS  Google Scholar 

  39. Ottenjann, R., Rösch, W.: Clinical and experimental studies on carbenoxolon sodium. In: Carbenoxolon sodium. Baron, J.H., Sullivan, F.M. (eds.), pp. 75–79. London: Butterworths 1970

    Google Scholar 

  40. Pürckhauer, V.: Gibt es neue Möglichkeiten in der Ulcustherapie? Therapiewoche27, 1643–1649(1977)

    Google Scholar 

  41. Scobie, B.A.: Gastric ulcer treatment with carbenoxolone sodium (“Biogastrone”). N. Z. med. J. 65, 308–309(1966)

    PubMed  CAS  Google Scholar 

  42. Sun, D.C.H.: Long-term anticholinergic therapy for prevention of recurrence in duodenal ulcer. Amer. J. dig. Dis. 9,706–716 (1964)

    Article  PubMed  CAS  Google Scholar 

  43. Tewari, S.N., Trembalowicz, P.B.: Some experience with deglycyrrhizinated liquorice in the treatment of gastric and duodenal ulcers with special reference to its spasmolytic effect. Gut 9,48–51 (1968)

    Article  PubMed  CAS  Google Scholar 

  44. Turpie, A.G.G., Thomson, T.J.: Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side effects. Gut 6, 591–594 (1965)

    Article  PubMed  CAS  Google Scholar 

  45. Walan, A.: Studies on peptic ulcer disease with special reference to the effect of hyoscyamine. Acta med. scand. 516 (suppl.), 1–57 (1970)

    CAS  Google Scholar 

  46. Wieck, H.H., Kallenberg, A., Liebler, G., Pauli, W., Posth, H.-E.: Klinische Untersuchungen zur Psychosomatik der Ulcuskrankheit. Neurologie 27, 133–160 (1959)

    CAS  Google Scholar 

Download references

Authors
  1. W.-P. Fritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik, Stadtspital Triemli, Birmendorfstraße 497, CH-8063, Zürich, Deutschland

    André Louis Blum

  2. Klinik und Poliklinik für Allgemeinchirurgie, Goßlerstraße 10, D-3400, Göttingen, Deutschland

    Jörg Rüdiger Siewert

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fritsch, WP. (1978). Andere Sekretionshemmer und Medikamente zur Förderung der Schleimhautresistenz. In: Blum, A.L., Siewert, J.R. (eds) Ulcus-Therapie. Interdisziplinäre Gastroenterologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96456-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96456-5_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-96457-2

  • Online ISBN: 978-3-642-96456-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation